Mindray Troponin I (CLIA) Reagent

Mindray Troponin I (cTnI) employs a two-site sandwich chemiluminescence immunoassay, delivering high sensitivity, excellent specificity, and rapid turnaround time.

It provides reliable early detection of cardiac injury, supports risk stratification, and enables effective clinical decision-making in emergency, critical care, and cardiology settings.

Each kit contains 2 × 50 tests, suitable for medium-to-high throughput laboratories.

Key Features

•  High-sensitivity CLIA method ensures early detection of myocardial injury

•  Two-site sandwich immunoassay for superior accuracy and specificity

•  Ready-to-use cartridges compatible with Mindray CLIA analyzers

•  Fast results ideal for emergency & critical care workflows

•  Low detection limit, minimizing false negatives

•  Excellent lot-to-lot stability and reproducibility

•  Essential biomarker for AMI, unstable angina & cardiac monitoring

Technical Specifications

Pack Size

• 2 × 50 Tests

• Includes required calibrator and controls (depending on kit configuration)

Applications

• Early detection of acute myocardial infarction (AMI)

• Assessment of unstable angina

• Evaluation of suspected cardiac injury

• Monitoring cardiac patients in ICU, CCU, ED, and cardiology units

• Part of routine cardiac biomarker panels

  (Troponin I, CK-MB, Myoglobin, NT-proBNP)